CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- Open-market buys, last 90 days
- $21,250
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$21,250. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-01 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $2.58 | $39K | 5,346,873 |
| 2022-06-21 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $2.80 | $56K | 5,331,873 |
| 2022-06-16 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $2.34 | $47K | 5,311,873 |
| 2022-06-13 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +30,000 | $2.29 | $69K | 5,291,873 |
| 2022-06-06 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +30,000 | $2.83 | $85K | 5,261,873 |
| 2022-06-01 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.03 | $61K | 5,231,873 |
| 2022-05-26 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.04 | $61K | 5,211,873 |
| 2022-05-23 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +18,355 | $2.72 | $50K | 5,191,873 |
| 2022-05-17 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +20,215 | $2.47 | $50K | 5,173,518 |
| 2022-05-13 | GORDON CARL L Director | Purchase | +30,722 | $2.49 | $76K | 14,817,994 |
| 2022-05-13 | ORBIMED ADVISORS LLC Director | Purchase | +30,722 | $2.49 | $76K | 14,817,994 |
| 2022-05-12 | GORDON CARL L Director | Purchase | +97,094 | $2.35 | $228K | 14,787,272 |
| 2022-05-12 | ORBIMED ADVISORS LLC Director | Purchase | +97,094 | $2.35 | $228K | 14,787,272 |
| 2022-05-11 | GORDON CARL L Director | Purchase | +64,700 | $1.79 | $116K | 14,690,178 |
| 2022-05-11 | ORBIMED ADVISORS LLC Director | Purchase | +64,700 | $1.79 | $116K | 14,690,178 |
| 2022-05-10 | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | Purchase | +27,836 | $1.80 | $50K | 5,153,303 |
| 2022-05-10 | ORBIMED ADVISORS LLC Director | Purchase | +24,447 | $1.60 | $39K | 14,625,478 |
| 2022-05-10 | GORDON CARL L Director | Purchase | +24,447 | $1.60 | $39K | 14,625,478 |
| 2022-05-09 | ORBIMED ADVISORS LLC Director | Purchase | +90,712 | $1.56 | $142K | 14,601,031 |
| 2022-05-09 | GORDON CARL L Director | Purchase | +90,712 | $1.56 | $142K | 14,601,031 |
Page 2 of 3 · 52 trades